Results 81 to 90 of about 2,365,116 (344)

Beyond RNA-binding domains: determinants of protein–RNA binding

RNA
RNA-binding proteins (RBPs) are composed of RNA-binding domains (RBDs) often linked via intrinsically disordered regions (IDRs). Structural and biochemical analyses have shown that disordered linkers contribute to RNA binding by orienting the adjacent RBDs and also characterized certain disordered repeats that directly contact the RNA.
Zigdon, Inbal, Carmi, Miri, Brodsky, Sagie, Rosenwaser, Zohar, Barkai, Naama, Jonas, Felix   +5 more
openaire   +2 more sources

RNA-binding protein nucleolin in disease [PDF]

RNA Biology, 2012
Nucleolin is a multifunctional protein localized primarily in the nucleolus, but also found in the nucleoplasm, cytoplasm and cell membrane. It is involved in several aspects of DNA metabolism, and participates extensively in RNA regulatory mechanisms, including transcription, ribosome assembly, mRNA stability and translation, and microRNA processing ...
Kotb Abdelmohsen, Myriam Gorospe
openaire   +3 more sources

RPI-Bind: a structure-based method for accurate identification of RNA-protein binding sites

Scientific Reports, 2017
RNA and protein interactions play crucial roles in multiple biological processes, while these interactions are significantly influenced by the structures and sequences of protein and RNA molecules.
Jiesi Luo, Liang Liu, Suresh Venkateswaran, Qianqian Song, Xiaobo Zhou   +4 more
doaj   +1 more source

Protein-mediated miRNA detection and siRNA enrichment using p19

BioTechniques, 2010
p19 RNA binding protein from the Carnation Italian ringspot virus (CIRV) is an RNA-silencing suppressor that binds small interfering RNA (siRNA) with high affinity.
Jingmin Jin, Melissa Cid, Catherine B. Poole, Larry A. McReynolds   +3 more
doaj   +1 more source

Single nucleotide polymorphisms affect RNA-protein interactions at a distance through modulation of RNA secondary structures.

PLoS Computational Biology, 2020
Single nucleotide polymorphisms are widely associated with disease, but the ways in which they cause altered phenotypes are often unclear, especially when they appear in non-coding regions. One way in which non-coding polymorphisms could cause disease is
Elan Shatoff, Ralf Bundschuh
doaj   +1 more source

Mechanistic implications of enhanced editing by a HyperTRIBE RNA-binding protein

bioRxiv, 2017
We previously developed TRIBE, a method for the identification of cell-specific RNA binding protein targets. TRIBE expresses an RBP of interest fused to the catalytic domain (cd) of the RNA editing enzyme ADAR and performs Adenosine-to-Inosine editing on
Weijin Xu, Reazur Rahman, M. Rosbash
semanticscholar   +1 more source

Insights into pegRNA design from editing of the cardiomyopathy‐associated phospholamban R14del mutation

FEBS Letters, EarlyView.
This study reveals how prime editing guide RNA (pegRNA) secondary structure and reverse transcriptase template length affect prime editing efficiency in correcting the phospholamban R14del cardiomyopathy‐associated mutation. Insights support the design of structurally optimized enhanced pegRNAs for precise gene therapy.
Bing Yao, Qiangbing Yang, Christian J.B. Snijders Blok, Mark A. Daniels, Pieter A. Doevendans, Raymond Schiffelers, Joost P.G. Sluijter, Zhiyong Lei   +7 more
wiley   +1 more source

RNA-Binding Proteins in Bladder Cancer

Cancers, 2023
RNA-binding proteins (RBPs) are key regulators of transcription and translation, with highly dynamic spatio-temporal regulation. They are usually involved in the regulation of RNA splicing, polyadenylation, and mRNA stability and mediate processes such as mRNA localization and translation, thereby affecting the RNA life cycle and causing the production
Yuanhui Gao, Hui Cao, Denggao Huang, Linlin Zheng, Zhenyu Nie, Shufang Zhang   +5 more
openaire   +2 more sources

Dysregulation of RNA Binding Protein Aggregation in Neurodegenerative Disorders

Frontiers in Molecular Neuroscience, 2017
The unique biology of RNA binding proteins is altering our view of the genesis of protein misfolding diseases. These proteins use aggregation of low complexity domains (LCDs) as a means to regulate the localization and utilization of RNA by forming RNA ...
Brandon F. Maziuk, Heather Ballance, B. Wolozin   +2 more
semanticscholar   +1 more source

Cyclic nucleotide signaling as a drug target in retinitis pigmentosa

FEBS Letters, EarlyView.
Disruptions in cGMP and cAMP signaling can contribute to retinal dysfunction and photoreceptor loss in retinitis pigmentosa. This perspective examines the mechanisms and evaluates emerging evidence on targeting these pathways as a potential therapeutic strategy to slow or prevent retinal degeneration.
Katri Vainionpää, Ahmed B. Montaser, Henri Leinonen   +2 more
wiley   +1 more source